Analysts Set Fortinet Inc (FTNT) Price Target at $56.40

Shares of Fortinet Inc (NASDAQ:FTNT) have earned a consensus recommendation of “Buy” from the twenty-six brokerages that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $57.11.

FTNT has been the subject of a number of recent research reports. BMO Capital Markets restated an “outperform” rating and set a $58.00 price objective (up from $50.00) on shares of Fortinet in a research note on Thursday, March 29th. Zacks Investment Research upgraded Fortinet from a “hold” rating to a “buy” rating and set a $61.00 price objective for the company in a research report on Monday, March 12th. Bank of America raised their price objective on Fortinet from $57.00 to $63.00 and gave the stock a “buy” rating in a research report on Tuesday, April 24th. Credit Suisse Group reiterated a “sell” rating and issued a $37.00 price objective on shares of Fortinet in a research report on Wednesday, February 28th. Finally, ValuEngine upgraded Fortinet from a “hold” rating to a “buy” rating in a research report on Wednesday, April 4th.

Get Fortinet alerts:

In other news, CEO Ken Xie sold 50,000 shares of the company’s stock in a transaction on Thursday, May 24th. The stock was sold at an average price of $60.51, for a total value of $3,025,500.00. Following the completion of the sale, the chief executive officer now owns 12,562,906 shares in the company, valued at $760,181,442.06. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP John Whittle sold 1,250 shares of the company’s stock in a transaction on Monday, June 18th. The shares were sold at an average price of $64.98, for a total value of $81,225.00. Following the completion of the sale, the vice president now owns 9,309 shares of the company’s stock, valued at approximately $604,898.82. The disclosure for this sale can be found here. In the last three months, insiders sold 84,214 shares of company stock valued at $5,052,515. 17.70% of the stock is owned by corporate insiders.

Several institutional investors have recently made changes to their positions in FTNT. Xact Kapitalforvaltning AB lifted its position in Fortinet by 6.4% during the 1st quarter. Xact Kapitalforvaltning AB now owns 14,953 shares of the software maker’s stock worth $801,000 after acquiring an additional 902 shares in the last quarter. Front Row Advisors LLC lifted its holdings in shares of Fortinet by 5.8% during the 1st quarter. Front Row Advisors LLC now owns 18,767 shares of the software maker’s stock worth $1,006,000 after acquiring an additional 1,032 shares during the last quarter. Oppenheimer Asset Management Inc. lifted its holdings in shares of Fortinet by 4.9% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 22,180 shares of the software maker’s stock worth $1,189,000 after acquiring an additional 1,035 shares during the last quarter. American Century Companies Inc. lifted its holdings in shares of Fortinet by 5.3% during the 4th quarter. American Century Companies Inc. now owns 24,786 shares of the software maker’s stock worth $1,083,000 after acquiring an additional 1,244 shares during the last quarter. Finally, Amalgamated Bank lifted its holdings in shares of Fortinet by 4.4% during the 4th quarter. Amalgamated Bank now owns 30,653 shares of the software maker’s stock worth $1,339,000 after acquiring an additional 1,287 shares during the last quarter. Institutional investors and hedge funds own 69.12% of the company’s stock.

Fortinet traded down $0.81, hitting $63.93, during mid-day trading on Tuesday, Marketbeat reports. The company’s stock had a trading volume of 2,293,344 shares, compared to its average volume of 1,484,412. Fortinet has a 12 month low of $35.44 and a 12 month high of $66.32. The company has a market capitalization of $10.88 billion, a PE ratio of 122.94, a P/E/G ratio of 4.41 and a beta of 0.76.

Fortinet (NASDAQ:FTNT) last posted its quarterly earnings data on Thursday, May 3rd. The software maker reported $0.33 EPS for the quarter, topping the consensus estimate of $0.24 by $0.09. Fortinet had a net margin of 4.01% and a return on equity of 14.64%. The business had revenue of $399.00 million for the quarter, compared to analyst estimates of $390.60 million. During the same quarter in the previous year, the firm posted $0.17 earnings per share. Fortinet’s quarterly revenue was up 17.1% on a year-over-year basis. analysts predict that Fortinet will post 0.88 earnings per share for the current year.

About Fortinet

Fortinet, Inc provides broad, automated, and integrated cybersecurity solutions worldwide. It offers FortiGate hardware and software licenses that provide various security and networking functions, including firewall, intrusion prevention, anti-malware, virtual private network, application control, Web filtering, anti-spam, and WAN acceleration; and FortiSandbox technology that delivers proactive detection and mitigation services; and FortiSIEM family of products, which offers a cloud-ready security information and event management solution for enterprises and service providers.

Analyst Recommendations for Fortinet (NASDAQ:FTNT)

Private Capital Group LLC Has $188,000 Holdings in Prologis Inc (PLD)

Private Capital Group LLC boosted its stake in Prologis Inc (NYSE:PLD) by 433.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,984 shares of the real estate investment trust’s stock after purchasing an additional 2,425 shares during the period. Private Capital Group LLC’s holdings in Prologis were worth $188,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. Goldman Sachs Group Inc. increased its stake in Prologis by 8.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 8,652,177 shares of the real estate investment trust’s stock worth $558,151,000 after purchasing an additional 638,453 shares during the period. Deutsche Bank AG increased its stake in Prologis by 77.4% in the 4th quarter. Deutsche Bank AG now owns 6,099,545 shares of the real estate investment trust’s stock worth $393,473,000 after purchasing an additional 2,661,525 shares during the period. Russell Investments Group Ltd. increased its stake in Prologis by 16.2% in the 1st quarter. Russell Investments Group Ltd. now owns 2,137,349 shares of the real estate investment trust’s stock worth $134,402,000 after purchasing an additional 297,716 shares during the period. Slow Capital Inc. purchased a new position in Prologis in the 4th quarter worth approximately $1,247,000. Finally, Swedbank increased its stake in Prologis by 32.4% in the 4th quarter. Swedbank now owns 2,699,585 shares of the real estate investment trust’s stock worth $174,150,000 after purchasing an additional 660,022 shares during the period. 94.19% of the stock is currently owned by institutional investors and hedge funds.

Get Prologis alerts:

Prologis opened at $63.95 on Friday, according to MarketBeat Ratings. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.66 and a current ratio of 0.66. Prologis Inc has a twelve month low of $56.59 and a twelve month high of $67.53. The company has a market cap of $34.19 billion, a P/E ratio of 22.76, a PEG ratio of 4.32 and a beta of 0.82.

Prologis (NYSE:PLD) last released its quarterly earnings results on Tuesday, April 17th. The real estate investment trust reported $0.68 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.35 by $0.33. Prologis had a return on equity of 9.86% and a net margin of 67.65%. The company had revenue of $555.90 million for the quarter, compared to analyst estimates of $552.42 million. During the same period in the previous year, the company posted $0.63 earnings per share. The firm’s revenue was down 1.9% on a year-over-year basis. research analysts predict that Prologis Inc will post 3 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, June 29th. Investors of record on Thursday, June 14th will be given a dividend of $0.48 per share. The ex-dividend date is Wednesday, June 13th. This represents a $1.92 annualized dividend and a dividend yield of 3.00%. Prologis’s dividend payout ratio is presently 68.33%.

In other Prologis news, Director William D. Zollars sold 4,750 shares of the business’s stock in a transaction on Friday, June 15th. The stock was sold at an average price of $64.06, for a total value of $304,285.00. Following the sale, the director now directly owns 19,510 shares of the company’s stock, valued at $1,249,810.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director J Michael Losh sold 3,618 shares of the business’s stock in a transaction on Friday, May 4th. The stock was sold at an average price of $65.38, for a total value of $236,544.84. Following the completion of the sale, the director now directly owns 24,957 shares in the company, valued at $1,631,688.66. The disclosure for this sale can be found here. Insiders have sold 41,121 shares of company stock worth $2,650,648 over the last 90 days. 1.31% of the stock is currently owned by corporate insiders.

A number of equities analysts have commented on the company. Zacks Investment Research cut Prologis from a “buy” rating to a “hold” rating in a research note on Tuesday. BMO Capital Markets reaffirmed a “buy” rating on shares of Prologis in a research note on Friday, May 18th. Citigroup reaffirmed a “buy” rating on shares of Prologis in a research note on Monday, April 30th. ValuEngine cut Prologis from a “buy” rating to a “hold” rating in a research note on Thursday, May 17th. Finally, Royal Bank of Canada set a $71.00 target price on Prologis and gave the company a “buy” rating in a research note on Wednesday, April 25th. Two equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $68.94.

Prologis Profile

Prologis, Inc is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of March 31, 2018, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 683 million square feet (63 million square meters) in 19 countries.

Want to see what other hedge funds are holding PLD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prologis Inc (NYSE:PLD).

Institutional Ownership by Quarter for Prologis (NYSE:PLD)

Hot Medical Stocks To Invest In Right Now

It’s hard to find a broader-based healthcare company than Johnson & Johnson (NYSE:JNJ). With exposure to everything from the most sophisticated medical devices and specially formulated prescription drug treatments to the items you’ve been buying off of drugstore shelves for years, J&J has its hand in everything related to healthcare. Despite taking a substantial one-time tax hit due to recent changes in the tax laws, Johnson & Johnson has been able to produce solid earnings even with some of its most successful treatments having lost patent protection and seeing a falloff in sales.

Coming into Tuesday’s first-quarter financial report, Johnson & Johnson shareholders were optimistic that the company would see its bottom line rebound as the positive impacts of tax reform would supplement solid fundamental business performance. J&J’s numbers were largely better than most had expected, thanks in part to strong performance from some of its most important treatments in the prescription drug segment, and the healthcare giant sees reasons to be even more excited about the rest of 2018 and beyond.

Hot Medical Stocks To Invest In Right Now: Empire State Realty Trust, Inc.(ESRT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Prudential Financial Inc. cut its stake in Empire State Realty (NYSE:ESRT) by 0.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,745,889 shares of the real estate investment trust’s stock after selling 8,046 shares during the quarter. Prudential Financial Inc.’s holdings in Empire State Realty were worth $29,313,000 at the end of the most recent quarter.

  • [By ]

    For example, nobody is going to come along and build another Empire State Building. In fact, you can actually invest in this building through the Empire State Realty Trust (NYSE: ESRT).

  • [By Logan Wallace]

    Kempen Capital Management N.V. purchased a new stake in Empire State Realty Trust Inc (NYSE:ESRT) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 602,051 shares of the real estate investment trust’s stock, valued at approximately $10,108,000.

Hot Medical Stocks To Invest In Right Now: Cherokee Inc.(CHKE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cherokee (NASDAQ:CHKE) released its quarterly earnings data on Thursday. The company reported ($0.20) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.09) by ($0.11), RTT News reports. Cherokee had a negative return on equity of 13.63% and a negative net margin of 130.24%. During the same quarter last year, the business posted ($0.07) earnings per share.

  • [By Garrett Baldwin]

    Following the June FOMC meeting, silver prices are hovering at very attractive price levels. With interest rates heading higher, it’s going to be a very good time for silver hounds to buy on the dip and deliver incredible profits in the months ahead.Learn more right here.

    The Top Stock Market Stories for Thursday
    On Thursday, the European Central Bank held its meeting in Latvia to discuss the future of its quantitative easing program. The central bank of the world’s largest economic bloc said that it will likely end its quantitative easing program in December. This represents an extension beyond the current plan to end the stimulus program in September. ECB President Mario Draghi said the program would be reduced to 15 billion euros each month during the final three months of the year. Yesterday, the U.S. Federal Reserve raised interest rates for the second time in 2018. The central bank said that economic growth has been rising at a solid rate and hinted that it could raise rates two more times this year. Fed Chair Jerome Powell did raise an alarm on Wednesday after stating that companies are holding back on investment due to ongoing concerns about U.S. President Donald Trump’s trade policies. Trump is expected to decide this week on whether to proceed with tariffs on about $50 billion in Chinese goods. Trade tensions are heating up again. This morning, China announced it would call off its deal to avoid a trade war if the Trump administration proceeds with tariffs on Friday morning. Tomorrow, the Trump team will decide if it will hit China with tariffs on roughly $50 billion in goods.
    Stocks to Watch Today: ADBE, CMCSA, TSLA, MSFT
    Adobe Systems Inc. (Nasdaq: ADBE) will report earnings after the bell Thursday. The software giant is expected to report earnings per share of $1.54 on top of $2.15 billion in revenue. Insider buying is alive and well at Tesla Inc. (Nasdaq: TSLA). Chair and CEO Elon Musk purchased $25 million in company stock, according to a

  • [By Max Byerly]

    Cherokee (NASDAQ: CHKE) and J.Jill (NYSE:JILL) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Hot Medical Stocks To Invest In Right Now: Primerica, Inc.(PRI)

Advisors’ Opinion:

  • [By Max Byerly]

    Great Lakes Advisors LLC bought a new position in shares of Primerica (NYSE:PRI) in the first quarter, according to the company in its most recent filing with the SEC. The firm bought 6,834 shares of the financial services provider’s stock, valued at approximately $660,000.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Joseph Griffin]

    Primerica (NYSE:PRI) has been assigned a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating. The average 1-year target price among brokers that have issued a report on the stock in the last year is $103.00.

  • [By Stephan Byrd]

    Wells Fargo & Company MN boosted its stake in Primerica (NYSE:PRI) by 2.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 838,510 shares of the financial services provider’s stock after purchasing an additional 19,142 shares during the quarter. Wells Fargo & Company MN’s holdings in Primerica were worth $81,000,000 as of its most recent SEC filing.

Hot Medical Stocks To Invest In Right Now: Tahoe Resources, Inc.(TAHO)

Advisors’ Opinion:

  • [By Shane Hupp]

    TheStreet lowered shares of Tahoe Resources (NYSE:TAHO) (TSE:THO) from a c rating to a d+ rating in a report published on Tuesday.

    A number of other research analysts also recently weighed in on TAHO. Cantor Fitzgerald assumed coverage on Tahoe Resources in a research note on Wednesday, March 28th. They set a buy rating on the stock. Zacks Investment Research downgraded Tahoe Resources from a hold rating to a sell rating in a research note on Thursday, April 26th. ValuEngine downgraded Tahoe Resources from a sell rating to a strong sell rating in a research note on Monday, April 2nd. Finally, Credit Suisse Group downgraded Tahoe Resources from an outperform rating to a neutral rating in a research note on Friday, January 26th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. Tahoe Resources has an average rating of Hold.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Tahoe Resources (TAHO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Tahoe Resources (TSE:THO) (NASDAQ:TAHO) – Equities research analysts at National Bank Financial reduced their FY2018 earnings estimates for shares of Tahoe Resources in a research report issued on Monday, April 9th. National Bank Financial analyst M. Parkin now forecasts that the company will earn $0.29 per share for the year, down from their prior forecast of $0.35. National Bank Financial currently has a “Sector Perform” rating and a $8.00 price objective on the stock.

Intel’s (INTC) “Neutral” Rating Reaffirmed at Sanford C. Bernstein

Sanford C. Bernstein reaffirmed their neutral rating on shares of Intel (NASDAQ:INTC) in a research note issued to investors on Thursday. They currently have a $54.00 price objective on the chip maker’s stock.

Other equities analysts also recently issued reports about the stock. Wells Fargo & Co reiterated a buy rating and issued a $65.00 price objective on shares of Intel in a report on Thursday. Stifel Nicolaus upped their price objective on shares of Intel from $57.00 to $60.00 and gave the company a hold rating in a report on Thursday. Vetr downgraded shares of Intel from a buy rating to a hold rating and set a $54.70 price objective on the stock. in a report on Wednesday, April 18th. Robert W. Baird reiterated a buy rating and issued a $62.00 price objective on shares of Intel in a report on Monday, March 26th. Finally, Argus upped their price objective on shares of Intel to $65.00 and gave the company a buy rating in a report on Monday, April 30th. They noted that the move was a valuation call. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and twenty-nine have issued a buy rating to the stock. Intel presently has a consensus rating of Buy and a consensus target price of $55.75.

Get Intel alerts:

Shares of Intel traded up $0.68, hitting $52.87, on Thursday, Marketbeat reports. The company had a trading volume of 243,463 shares, compared to its average volume of 25,158,368. Intel has a 1-year low of $33.23 and a 1-year high of $57.60. The company has a market cap of $250.10 billion, a P/E ratio of 15.29, a P/E/G ratio of 1.65 and a beta of 0.95. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.58 and a quick ratio of 1.23.

Intel (NASDAQ:INTC) last released its quarterly earnings data on Thursday, April 26th. The chip maker reported $0.87 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.72 by $0.15. Intel had a net margin of 17.32% and a return on equity of 25.41%. The firm had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.08 billion. During the same period in the previous year, the company earned $0.66 earnings per share. The company’s quarterly revenue was up 8.8% on a year-over-year basis. equities research analysts expect that Intel will post 3.84 earnings per share for the current year.

In other news, EVP Navin Shenoy sold 1,010 shares of the stock in a transaction dated Wednesday, May 2nd. The shares were sold at an average price of $52.80, for a total value of $53,328.00. Following the completion of the transaction, the executive vice president now owns 32,920 shares of the company’s stock, valued at $1,738,176. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Brian M. Krzanich sold 3,072 shares of the stock in a transaction dated Wednesday, May 2nd. The stock was sold at an average price of $52.78, for a total transaction of $162,140.16. Following the completion of the transaction, the chief executive officer now directly owns 259,683 shares of the company’s stock, valued at approximately $13,706,068.74. The disclosure for this sale can be found here. Insiders sold 13,192 shares of company stock valued at $693,559 in the last three months. Company insiders own 0.03% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Goodman Financial Corp bought a new position in Intel in the 4th quarter valued at approximately $102,000. Virtue Capital Management LLC bought a new position in Intel in the 4th quarter valued at approximately $109,000. Elmwood Wealth Management Inc. bought a new position in Intel in the 1st quarter valued at approximately $110,000. Financial Gravity Wealth Inc. bought a new position in Intel in the 1st quarter valued at approximately $120,000. Finally, Delphi Private Advisors LLC raised its holdings in Intel by 286.1% in the 4th quarter. Delphi Private Advisors LLC now owns 2,911 shares of the chip maker’s stock valued at $134,000 after buying an additional 2,157 shares during the last quarter. Institutional investors and hedge funds own 66.85% of the company’s stock.

About Intel

Intel Corporation designs, manufactures, and sells computer, networking, data storage, and communication platforms worldwide. The company operates through Client Computing Group, Data Center Group, Internet of Things Group, Non-Volatile Memory Solutions Group, Programmable Solutions Group, and All Other segments.

Analyst Recommendations for Intel (NASDAQ:INTC)

Qorvo Inc (QRVO) Receives Average Rating of “Hold” from Brokerages

Qorvo Inc (NASDAQ:QRVO) has been given a consensus recommendation of “Hold” by the twenty-seven analysts that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and ten have given a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $83.41.

QRVO has been the topic of several recent research reports. Barclays raised Qorvo from an “equal weight” rating to an “overweight” rating and set a $87.00 price target on the stock in a report on Tuesday, May 1st. JPMorgan Chase & Co. set a $92.00 target price on Qorvo and gave the company a “buy” rating in a research report on Friday, March 16th. Needham & Company LLC restated a “buy” rating and issued a $85.00 target price on shares of Qorvo in a research report on Thursday, May 3rd. Nomura cut Qorvo from a “buy” rating to a “neutral” rating and lowered their target price for the company from $85.00 to $75.00 in a research report on Tuesday, March 20th. Finally, Morgan Stanley lowered their target price on Qorvo from $74.00 to $72.00 and set an “equal weight” rating on the stock in a research report on Monday, April 30th.

Get Qorvo alerts:

Shares of Qorvo traded down $0.18, hitting $82.05, during mid-day trading on Monday, according to Marketbeat.com. The company had a trading volume of 1,580,911 shares, compared to its average volume of 1,305,771. The company has a market cap of $10.40 billion, a price-to-earnings ratio of 17.17, a price-to-earnings-growth ratio of 1.34 and a beta of 1.00. Qorvo has a 12 month low of $62.68 and a 12 month high of $86.84. The company has a current ratio of 4.18, a quick ratio of 3.11 and a debt-to-equity ratio of 0.21.

Qorvo (NASDAQ:QRVO) last announced its quarterly earnings results on Wednesday, May 2nd. The semiconductor company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.02. The business had revenue of $665.40 million for the quarter, compared to the consensus estimate of $655.67 million. Qorvo had a positive return on equity of 12.50% and a negative net margin of 1.35%. The business’s revenue was up 3.5% on a year-over-year basis. During the same quarter last year, the business posted $0.85 EPS. equities analysts forecast that Qorvo will post 5.14 earnings per share for the current fiscal year.

In other news, VP Steven E. Creviston sold 6,000 shares of Qorvo stock in a transaction on Monday, April 16th. The stock was sold at an average price of $72.75, for a total transaction of $436,500.00. Following the transaction, the vice president now directly owns 64,725 shares in the company, valued at approximately $4,708,743.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Daniel A. Dileo sold 1,625 shares of Qorvo stock in a transaction on Wednesday, May 16th. The shares were sold at an average price of $80.75, for a total value of $131,218.75. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 60,404 shares of company stock worth $4,798,110. 0.91% of the stock is owned by insiders.

Several hedge funds have recently modified their holdings of the company. Blackhawk Capital Partners LLC. boosted its stake in shares of Qorvo by 23.9% during the 1st quarter. Blackhawk Capital Partners LLC. now owns 3,390 shares of the semiconductor company’s stock worth $239,000 after acquiring an additional 655 shares in the last quarter. Suntrust Banks Inc. boosted its stake in shares of Qorvo by 3.6% during the 1st quarter. Suntrust Banks Inc. now owns 19,596 shares of the semiconductor company’s stock worth $1,379,000 after acquiring an additional 686 shares in the last quarter. Norinchukin Bank The boosted its stake in shares of Qorvo by 7.4% during the 4th quarter. Norinchukin Bank The now owns 10,176 shares of the semiconductor company’s stock worth $678,000 after acquiring an additional 703 shares in the last quarter. Nomura Asset Management Co. Ltd. boosted its stake in shares of Qorvo by 3.8% during the 1st quarter. Nomura Asset Management Co. Ltd. now owns 19,072 shares of the semiconductor company’s stock worth $1,343,000 after acquiring an additional 703 shares in the last quarter. Finally, Xact Kapitalforvaltning AB boosted its stake in shares of Qorvo by 2.7% during the 1st quarter. Xact Kapitalforvaltning AB now owns 27,451 shares of the semiconductor company’s stock worth $1,934,000 after acquiring an additional 730 shares in the last quarter. Institutional investors own 97.51% of the company’s stock.

About Qorvo

Qorvo, Inc provides radio frequency (RF) solutions and technologies for mobile device, infrastructure, and defense and aerospace applications worldwide. It operates through Mobile Products (MP) and Infrastructure and Defense Products (IDP) segments. The MP segment offers cellular RF and WiFi solutions, bulk acoustic wave (BAW) and surface acoustic wave (SAW) filters, power amplifiers (PA), low noise amplifiers, switches, multi-band PAs and transmit modules, RF power management integrated circuits, diversity receive modules, antenna switch modules, antenna tuning and control solutions, modules incorporating PAs and duplexers, and modules incorporating switches, PAs, and duplexers.

Analyst Recommendations for Qorvo (NASDAQ:QRVO)

Top 5 Warren Buffett Stocks To Own Right Now

Warren Buffett often jokes that he gets a quarter of his daily caloric intake from Coca-Cola. But an investment firm is suggesting that Kraft Heinz, which Buffett’s Berkshire Hathaway owns a nearly 27 percent stake in, may want to buy Coke rival Pepsi.

Fixed income research shop CreditSights said in a report this week that Kraft Heinz (KHC) appears to still be itching to do a deal.

European consumer products conglomerate Unilever (UL), the owner of Lipton and Ben & Jerry’s as well as the Dove brand of personal care goods, rejected a more than $140 billion bid from Kraft Heinz earlier this year.

Unilever said at the time that the deal “fundamentally undervalues” the company and that “it sees no merit, either financial or strategic, for Unilever’s shareholders.”

Kraft Heinz subsequently withdrew its offer instead of pursuing it further. And that’s led to speculation ever since about what Kraft Heinz might target next.

The CreditSights analysts noted that Buffett has already ruled out the possibility that Kraft Heinz could buy Mondelez (MDLZ), the Oreo and Cadbury owner that split from Kraft Foods in 2012. (Kraft Foods subsequently merged with Heinz in 2015.)

Top 5 Warren Buffett Stocks To Own Right Now: Approach Resources Inc.(AREX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Approach Resources (AREX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Warren Buffett Stocks To Own Right Now: (LGF.A)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Lions Gate Entertainment Corp. Class A (NYSE:LGF.A) announced a quarterly dividend on Friday, June 8th, Zacks reports. Investors of record on Saturday, June 30th will be given a dividend of 0.09 per share on Thursday, August 9th. This represents a $0.36 annualized dividend and a yield of 1.34%. The ex-dividend date is Thursday, June 28th.

  • [By Stephan Byrd]

    Lionsgate (NYSE: LGF.A) and Genius Brands (NASDAQ:GNUS) are both consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, earnings, analyst recommendations, profitability and risk.

  • [By Stephan Byrd]

    World Wrestling Entertainment (NYSE: WWE) and Lions Gate Entertainment Corp. Class A (NYSE:LGF.A) are both mid-cap consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

  • [By Stephan Byrd]

    Lionsgate (NYSE:LGF.A) was downgraded by equities research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Wednesday.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Lionsgate (LGF.A)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Warren Buffett Stocks To Own Right Now: RAIT Financial Trust(RAS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    RAIT Financial Trust (NYSE:RAS) will announce its earnings results before the market opens on Wednesday, May 23rd. Analysts expect the company to announce earnings of $0.21 per share for the quarter.

Top 5 Warren Buffett Stocks To Own Right Now: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    PRA Group (NASDAQ:PRAA) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a report released on Monday.

  • [By Dan Caplinger]

    Like many businesses, debt collection is a cyclical industry, and as a major player in that industry, PRA Group (NASDAQ:PRAA) is subject to the ups and downs of the economy. During good times, there aren’t as many nonperforming loans for PRA Group to collect on. Only when times get tough do default rates move higher, spurring many creditors to turn their collections over to PRA.

  • [By Logan Wallace]

    Carillon Tower Advisers Inc. raised its stake in PRA Group (NASDAQ:PRAA) by 706.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 84,032 shares of the business services provider’s stock after buying an additional 73,617 shares during the quarter. Carillon Tower Advisers Inc. owned about 0.19% of PRA Group worth $3,193,000 at the end of the most recent quarter.

Top 5 Warren Buffett Stocks To Own Right Now: InterXion Holding N.V.(INXN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Interxion (NYSE:INXN) was the target of unusually large options trading on Tuesday. Traders acquired 960 call options on the company. This is an increase of 1,584% compared to the typical daily volume of 57 call options.

  • [By Stephan Byrd]

    Interxion (NYSE:INXN) had its price objective boosted by Citigroup from $68.00 to $75.00 in a research note issued to investors on Friday morning. Citigroup currently has a buy rating on the technology company’s stock.

  • [By Max Byerly]

    Jacobson & Schmitt Advisors LLC lessened its holdings in shares of Interxion (NYSE:INXN) by 1.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 102,697 shares of the technology company’s stock after selling 1,927 shares during the quarter. Interxion comprises approximately 4.4% of Jacobson & Schmitt Advisors LLC’s portfolio, making the stock its 5th biggest holding. Jacobson & Schmitt Advisors LLC owned 0.14% of Interxion worth $6,378,000 at the end of the most recent quarter.

Eco-Stim Energy Solutions (ESES) Receiving Somewhat Favorable Media Coverage, Study Finds

Press coverage about Eco-Stim Energy Solutions (NASDAQ:ESES) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Eco-Stim Energy Solutions earned a daily sentiment score of 0.12 on Accern’s scale. Accern also assigned media coverage about the oil and gas company an impact score of 47.1001025646776 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

A number of equities research analysts recently weighed in on the company. ValuEngine upgraded Eco-Stim Energy Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, June 2nd. B. Riley set a $2.00 price objective on Eco-Stim Energy Solutions and gave the stock a “buy” rating in a research note on Tuesday, May 22nd. Imperial Capital cut Eco-Stim Energy Solutions from an “outperform” rating to an “in-line” rating and set a $2.00 price objective for the company. in a research note on Wednesday, May 16th. Finally, Zacks Investment Research cut Eco-Stim Energy Solutions from a “hold” rating to a “sell” rating in a research note on Monday, May 14th. One research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. Eco-Stim Energy Solutions has an average rating of “Hold” and an average price target of $2.20.

Get Eco-Stim Energy Solutions alerts:

Shares of Eco-Stim Energy Solutions traded up $0.03, reaching $0.83, during mid-day trading on Friday, according to Marketbeat. 6,722 shares of the company were exchanged, compared to its average volume of 45,938. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.59 and a quick ratio of 0.50. The stock has a market capitalization of $59.90 million, a P/E ratio of -3.19 and a beta of 2.19. Eco-Stim Energy Solutions has a 1 year low of $0.76 and a 1 year high of $1.74.

Eco-Stim Energy Solutions (NASDAQ:ESES) last issued its quarterly earnings data on Monday, May 14th. The oil and gas company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.11). The company had revenue of $17.78 million for the quarter, compared to analysts’ expectations of $24.38 million. Eco-Stim Energy Solutions had a negative return on equity of 40.56% and a negative net margin of 58.72%. equities research analysts anticipate that Eco-Stim Energy Solutions will post -0.32 earnings per share for the current fiscal year.

Eco-Stim Energy Solutions Company Profile

Eco-Stim Energy Solutions, Inc provides oilfield services in the United States and Argentina. The company offers pressure pumping, coiled tubing, and field management services to the upstream oil and gas industry. Its customers consist primarily of international oil and gas exploration and production companies, including national oil companies, local privately-held exploration and production companies, and other service companies.

Insider Buying and Selling by Quarter for Eco-Stim Energy Solutions (NASDAQ:ESES)

Worthington Industries, Inc. (WOR) Expected to Post Quarterly Sales of $935.34 Million

Wall Street analysts expect Worthington Industries, Inc. (NYSE:WOR) to report sales of $935.34 million for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Worthington Industries’ earnings. The highest sales estimate is $971.00 million and the lowest is $899.68 million. Worthington Industries posted sales of $845.34 million during the same quarter last year, which would indicate a positive year over year growth rate of 10.6%. The firm is expected to announce its next earnings report on Wednesday, June 27th.

According to Zacks, analysts expect that Worthington Industries will report full year sales of $3.50 billion for the current year, with estimates ranging from $3.46 billion to $3.53 billion. For the next financial year, analysts forecast that the business will report sales of $3.73 billion per share, with estimates ranging from $3.63 billion to $3.84 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that cover Worthington Industries.

Get Worthington Industries alerts:

Worthington Industries (NYSE:WOR) last issued its earnings results on Thursday, March 29th. The industrial products company reported $0.61 earnings per share for the quarter, missing the consensus estimate of $0.75 by ($0.14). The firm had revenue of $841.66 million during the quarter, compared to the consensus estimate of $863.50 million. Worthington Industries had a return on equity of 17.05% and a net margin of 6.47%. The company’s quarterly revenue was up 19.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.55 EPS.

Several brokerages recently weighed in on WOR. ValuEngine downgraded shares of Worthington Industries from a “buy” rating to a “hold” rating in a report on Wednesday, May 2nd. Jefferies Financial Group reaffirmed a “hold” rating and issued a $45.00 target price on shares of Worthington Industries in a report on Friday, March 30th. Finally, Zacks Investment Research downgraded shares of Worthington Industries from a “hold” rating to a “strong sell” rating in a report on Saturday, April 7th.

Worthington Industries stock traded up $0.28 during mid-day trading on Tuesday, hitting $47.94. The stock had a trading volume of 9,287 shares, compared to its average volume of 250,633. The company has a market capitalization of $2.98 billion, a P/E ratio of 14.88, a P/E/G ratio of 3.40 and a beta of 1.08. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.05. Worthington Industries has a one year low of $39.52 and a one year high of $53.27.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 29th. Shareholders of record on Friday, June 15th will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 1.75%. The ex-dividend date of this dividend is Thursday, June 14th. Worthington Industries’s dividend payout ratio (DPR) is presently 26.09%.

In related news, Director Michael J. Endres acquired 3,000 shares of the company’s stock in a transaction on Wednesday, April 4th. The stock was acquired at an average price of $39.78 per share, with a total value of $119,340.00. Following the acquisition, the director now directly owns 187,440 shares of the company’s stock, valued at $7,456,363.20. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Catherine M. Lyttle sold 34,500 shares of the stock in a transaction dated Wednesday, April 4th. The shares were sold at an average price of $40.65, for a total transaction of $1,402,425.00. Following the transaction, the vice president now directly owns 32,059 shares of the company’s stock, valued at approximately $1,303,198.35. The disclosure for this sale can be found here. 31.30% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the company. PDS Planning Inc purchased a new stake in shares of Worthington Industries during the 1st quarter valued at about $185,000. Raymond James Financial Services Advisors Inc. purchased a new stake in shares of Worthington Industries during the 4th quarter valued at about $218,000. Xact Kapitalforvaltning AB purchased a new stake in shares of Worthington Industries during the 4th quarter valued at about $221,000. Elkfork Partners LLC purchased a new stake in shares of Worthington Industries during the 4th quarter valued at about $234,000. Finally, Flinton Capital Management LLC raised its position in shares of Worthington Industries by 24.2% during the 4th quarter. Flinton Capital Management LLC now owns 6,460 shares of the industrial products company’s stock valued at $285,000 after buying an additional 1,258 shares in the last quarter. Hedge funds and other institutional investors own 50.36% of the company’s stock.

Worthington Industries Company Profile

Worthington Industries, Inc, a metals manufacturing company, focuses on value-added steel processing and manufactured metal products in the United States, Austria, Canada, Mexico, Poland, Portugal, and Turkey. The company operates through three segments: Steel Processing, Pressure Cylinders, and Engineered Cabs.

Get a free copy of the Zacks research report on Worthington Industries (WOR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Worthington Industries (NYSE:WOR)

Millennium Management LLC Has $52.32 Million Stake in BioMarin Pharmaceutical Inc. (BMRN)

Millennium Management LLC grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 1.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 645,400 shares of the biotechnology company’s stock after acquiring an additional 10,536 shares during the quarter. Millennium Management LLC’s holdings in BioMarin Pharmaceutical were worth $52,323,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in BMRN. Barings LLC purchased a new position in shares of BioMarin Pharmaceutical in the 4th quarter valued at $343,000. Toronto Dominion Bank increased its holdings in shares of BioMarin Pharmaceutical by 40.2% in the 4th quarter. Toronto Dominion Bank now owns 10,329 shares of the biotechnology company’s stock valued at $921,000 after acquiring an additional 2,960 shares during the period. State of Wisconsin Investment Board increased its holdings in shares of BioMarin Pharmaceutical by 81.0% in the 4th quarter. State of Wisconsin Investment Board now owns 91,577 shares of the biotechnology company’s stock valued at $8,166,000 after acquiring an additional 40,970 shares during the period. Arizona State Retirement System boosted its position in shares of BioMarin Pharmaceutical by 7.5% in the 4th quarter. Arizona State Retirement System now owns 33,234 shares of the biotechnology company’s stock worth $2,963,000 after purchasing an additional 2,328 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. acquired a new stake in shares of BioMarin Pharmaceutical in the 4th quarter worth $224,000.

Get BioMarin Pharmaceutical alerts:

Shares of BioMarin Pharmaceutical stock opened at $98.43 on Friday. The company has a quick ratio of 2.29, a current ratio of 2.90 and a debt-to-equity ratio of 0.29. BioMarin Pharmaceutical Inc. has a twelve month low of $75.81 and a twelve month high of $100.03. The stock has a market capitalization of $17.38 billion, a P/E ratio of -146.91 and a beta of 1.71.

BioMarin Pharmaceutical (NASDAQ:BMRN) last announced its quarterly earnings results on Wednesday, April 25th. The biotechnology company reported ($0.25) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.17) by ($0.08). BioMarin Pharmaceutical had a negative net margin of 10.48% and a negative return on equity of 3.01%. The business had revenue of $373.45 million during the quarter, compared to analysts’ expectations of $348.73 million. During the same quarter in the prior year, the firm earned $0.20 EPS. BioMarin Pharmaceutical’s revenue for the quarter was up 22.9% on a year-over-year basis. analysts forecast that BioMarin Pharmaceutical Inc. will post -0.12 earnings per share for the current fiscal year.

In related news, SVP Brian Mueller sold 2,021 shares of BioMarin Pharmaceutical stock in a transaction dated Friday, June 15th. The stock was sold at an average price of $94.50, for a total value of $190,984.50. Following the completion of the transaction, the senior vice president now owns 13,029 shares in the company, valued at approximately $1,231,240.50. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Jeffrey Robert Ajer sold 1,537 shares of BioMarin Pharmaceutical stock in a transaction dated Thursday, March 29th. The shares were sold at an average price of $79.69, for a total value of $122,483.53. Following the completion of the transaction, the executive vice president now owns 55,033 shares of the company’s stock, valued at approximately $4,385,579.77. The disclosure for this sale can be found here. In the last 90 days, insiders sold 170,681 shares of company stock valued at $14,810,686. 1.90% of the stock is owned by company insiders.

A number of analysts have recently weighed in on BMRN shares. JPMorgan Chase & Co. set a $127.00 price objective on BioMarin Pharmaceutical and gave the stock a “buy” rating in a research report on Thursday, April 26th. ValuEngine raised BioMarin Pharmaceutical from a “sell” rating to a “hold” rating in a research report on Monday, May 28th. Canaccord Genuity raised their price objective on BioMarin Pharmaceutical from $101.00 to $105.00 and gave the stock a “buy” rating in a research report on Friday, May 25th. Royal Bank of Canada reissued a “hold” rating and issued a $94.00 price objective on shares of BioMarin Pharmaceutical in a research report on Tuesday, February 27th. Finally, Morgan Stanley lowered their price objective on BioMarin Pharmaceutical from $115.00 to $112.00 and set an “overweight” rating for the company in a research report on Friday, February 23rd. One investment analyst has rated the stock with a sell rating, six have given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $112.50.

About BioMarin Pharmaceutical

BioMarin Pharmaceutical, Inc, a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Aldurazyme that is used for the treatment of patients with mucopolysaccharidosis I, a genetic disease; Brineura for the treatment of late infantile neuronal ceroid lipofuscinosis type 2, a form of Batten disease; and Firdapse for Lambert Eaton Myasthenic Syndrome.

Want to see what other hedge funds are holding BMRN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN).

Institutional Ownership by Quarter for BioMarin Pharmaceutical (NASDAQ:BMRN)

How OPEC Is Holding Its Oil Output Curbs in Place

LISTEN TO ARTICLE 4:17 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

How intent is the Organization of Petroleum Exporting Countries to stick to output curbs put in place 18 months ago? Intent enough to raise oil production to keep the agreement in place. The global petroleum-cuts pact reached in late 2016 by OPEC’s 14 members and 10 non-members including Russia, succeeded in ending a three-year slump in the price of oil. Now OPEC and its partners have reached a follow-up deal allowing Saudi Arabia and Russia to achieve their goal of raising oil production — which may partially soothe consumer concerns after benchmark Brent touched $80 a barrel in May.

1. What exactly is OPEC doing?

It agreed to boost oil production from July 1, an 11th-hour compromise after Iran initially threatened to veto any supply hike. The 14-nation cartel, with its allies, will bring production cuts back to the target of 1.8 million barrels a day, set in 2016. While in theory that could mean extra output of 1 million barrels a day, in practice the figure could be lower — 600,000 to 800,000 barrels a day — as some producers are unable to pump more. This will be accomplished by some nations such as Saudi Arabia effectively rolling back deeper-than-intended cuts.

2. Is this a change of course?

Not exactly. The output curbs of late 2016 — forged among OPEC and 10 oil producers outside the cartel — remain in place. In an acknowledgment of how successful that pact has been in raising prices, the cartel recommitted itself to aim for 100 percent compliance with the deal. That’s a group target, which will give scope to nations such as Saudi Arabia and Russia to increase output. It also implies a transfer in market share from Venezuela and Iran.

3. Was OPEC swayed by political pressure?

Perhaps. OPEC has been buffeted by competing geopolitical agendas. Some of the world’s biggest consumers — the U.S., China and India — have pushed the group to open the taps, while Venezuela and Iran want higher prices to compensate for the impact of American sanctions. U.S. President Donald Trump criticized OPEC on Twitter for inflating the cost of fuel. His administration quietly asked Saudi Arabia and some other OPEC producers to increase oil production by about 1 million barrels a day. The kingdom has been quick to acknowledge the needs of consumers in recent weeks, even as it sought to preserve the hard-won unity of OPEC and its partners.

4. What explains Iran’s dissent?

On Thursday evening, a deal looked to be slipping away after Iranian Oil Minister Bijan Namdar Zanganeh walked out of a meeting with fellow ministers, predicting nobody could persuade him to back an increase. Iran has bridled at Trump’s intervention into the cartel’s policy. Zanganeh has said the U.S. president is to blame for high prices because of his unilateral withdrawal from the international nuclear agreement and the imposition of fresh sanctions that could significantly curb Iran’s crude exports.

5. What does this say about OPEC’s continuing influence?

OPEC’s obituary has been written many times, but since its creation more than a half-century ago, the cartel has been jolting the world. It’s latest alliance has already defied many doubters as the world’s two largest oil exporters — Saudi Arabia and Russia — increasingly dominate policy discussions. Those two heavyweights are even considering inviting all 24 countries to join a permanent body with its own constitution and secretariat. That would mark a seismic shift in oil’s world order.

6. What does this mean for oil prices going forward?

Oil prices reacted favorably to OPEC’s compromise deal, with futures in the U.S. gaining as much as 4.9 percent as ministers left their meeting in Vienna. OPEC stressed that it targets market stability rather than prices, but the longer-term outlook for both looks uncertain. Saudi Arabia might agree with Iran’s analysis that $70 is a very good price for oil, while Russia is prepared for a slightly lower level. Much will depend on how much extra crude comes back on to the market, the robustness of American shale drillers, the fate of Venezuela’s crisis-hit oil industry and the impact of U.S. sanctions on Iran.

The Reference ShelfThis Bloomberg graphic shows which countries are reaching their targets for oil production cuts.OPEC enshrined its main objectives in a 1961 statute.QuickTake explainers on shale’s threat to OPEC